Is BBG70 Stack from Lumera Labs HPLC verified?

Yes. Every BBG70 Stack lot Lumera Labs ships is HPLC-purity tested at synthesis and retested by Janoshik Analytical before release. The lot-specific Certificate of Analysis is published on the Lab Results page.

Is BBG70 Stack sold for human use?

No. BBG70 Stack is sold strictly as a laboratory reference standard for in-vitro research. It is not approved by Health Canada or the FDA for human use. Every order requires a research-use declaration.

How is BBG70 Stack shipped?

BBG70 Stack is lyophilized at synthesis, sealed under nitrogen, and shipped from Kelowna, BC at -20 C through cold-chain insulated packaging via Canada Post Xpresspost. Free shipping over $200 CAD. 24-48h transit Canada-wide.

Where can I see the COA for BBG70 Stack?

Each shipment includes a lot-specific Certificate of Analysis. The current lot's COA is also published at https://lumerapeptide.com/lab-results/ and can be cross-referenced by the batch number printed on each vial.

Home / Catalog / Healing / Triple (BBG70) Stack 1 mg

4.9 · 234 researcher reviews

Healing · Investigational pre-blend

Triple (BBG70) Stack

SKU LUM-BBG70-10 · Investigational pre-blend · Mixed components · CAS Per-component reference

An investigational pre-blended research peptide stack supplied as a lyophilized reference standard. Component identities disclosed on the lot-specific Certificate of Analysis.

Purity (HPLC): ≥ 99.1%
Net peptide: 5.00 mg ± 2%
Endotoxin: < 0.5 EU/mg
Format: Lyophilized vial
Storage: −20 °C, desiccated
Shelf life: 24 months from MFG

$160CAD / 1 mg vial

In stock · Lot 26-A031

Qty

Bulk 10+: $24 / vial

Add $200 for free cold-chain shipping

HPLC + MS verified per lot
Cold-chain to your door
COA bundled with shipment
Lot retains kept 5 years

Overview

The BBG70 Stack is an investigational research blend provided as a co-lyophilized reference standard. Component identities, mass ratios, and HPLC purity per component are disclosed on the lot-specific Certificate of Analysis.

Each vial is lyophilized from acetate buffer, sealed under nitrogen, and shipped cold-chain at −20 °C from our Kelowna facility.

Research applications

Multi-mechanism healing-axis investigations, comparative pharmacology screens, and reference-standard use for stack-based research protocols.

Sold for laboratory research only. This material is not a drug, food, or cosmetic and is not intended for diagnostic, therapeutic, or recreational use.

Identity

Parameter	Value
Sequence	Investigational research blend (component sequences disclosed on COA)
Molecular formula	Investigational pre-blend
Molecular weight	Mixed components
CAS number	Per-component reference
Length	Pre-blend

Quality

Test	Specification
HPLC purity	≥ 99.0% (lot LM-2655: ≥ 99% per component)
Mass confirmation	ESI-MS within 0.5 Da
Net peptide content	≥ 80% by AAA
Endotoxin	< 0.5 EU/mg (LAL)
Bioburden	< 10 CFU/g
Residual TFA	< 1.0%

Lot LM-2655

Manufactured 04 Mar 2026 · Released 11 Mar 2026 · Tested by Lumera QC, Kelowna BC. Retain samples held under storage spec for five years from release date.

Verification

Method	Result
RP-HPLC at 220 nm	≥ 99% per component main peak
ESI-MS (positive)	Multiple peaks (per COA)
Amino acid analysis	82.1% net peptide
LAL endotoxin	< 0.05 EU/mg
Karl Fischer (water)	2.8% w/w

Reconstitution

Allow vial to reach room temperature before opening (≥ 20 minutes). Reconstitute with 1.0–2.5 mL of sterile bacteriostatic water (0.9% benzyl alcohol). Inject solvent slowly down the inner wall of the vial; do not direct stream onto the lyophilized cake.

Swirl gently for 30 seconds. Do not vortex. Allow to dissolve for 5 minutes; clarity should be complete with no visible particulates.

Storage after reconstitution

Reconstituted solution is stable for 28 days at 2–8 °C in original vial. For longer storage, aliquot into low-binding tubes and hold at −80 °C; avoid repeated freeze-thaw cycles. Discard if turbidity, color change, or particulate matter is observed.